• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XPT RUBELLA G (RUB G); RUBELLA G IMMUNOASSAY,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XPT RUBELLA G (RUB G); RUBELLA G IMMUNOASSAY, Back to Search Results
Model Number N/A
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/23/2019
Event Type  malfunction  
Manufacturer Narrative
Siemens' investigation is complete.There was no sample(s) available for further evaluation and the sample(s) was not tested with heterophilic blocking tubes (hbt).Customer denied field service to check the system and did not question any other patient results for any of the assays performed on the system.Root cause of the reproducible positiveadvia centaur xpt rub g results cannot be determined but this seems to be isolated to this patient sample.The region has not been able to provide additional information and clarification that is needed to calculate the relative specificity on this account with rub g lot 216.The initial relative specificity of 3 studies in the advia centaur xpt rubella igg ((b)(4)) instructions for use (ifu) has a range of 95.4-100%.The instructions for use states in the warning section: "the use of the advia centaur rubella g assay to diagnose recent infection by testing acute and convalescent samples is not recommended.The calculated values for rubella igg in a given specimen, as determined by assays from different manufacturers, can vary due to differences in assay methods and reagent specificity.The results reported by the laboratory to the physician must include the identity of the rubella igg assay used.Values obtained with different assay methods cannot be used interchangeably.The reported igg level cannot be correlated to an endpoint titer." based on the available information advia centaur xpt rubella g lot 216 is performing as intended.No further evaluation of the device is required.Mdr 1219913-2019-00236 (for advia centaur xpt result from (b)(6) 2019) was filed for the same issue.
 
Event Description
A false positive result was obtained on a patient sample with advia centaur xpt for rubella g (rub g).The result was reported and questioned by the physician.A second sample was collected from the same patient and sent to an alternate laboratory where a negative rub g result and a positive rubeola result were obtained using unknown test methods.A third sample was collected from the same patient and tested for rub g on the same advia centaur xpt instrument and a positive result was reproduced.Complaint information indicated that calibration and quality control results were in range, but no data was provided.Patient treatment was not prescribed or altered.There was no report of adverse health consequences due to the positive rubella g results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XPT RUBELLA G (RUB G)
Type of Device
RUBELLA G IMMUNOASSAY,
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
333 coney street
east walpole MA 02032
Manufacturer Contact
stacy loukos
333 coney street
east walpole, MA 02032
5086608576
MDR Report Key9338726
MDR Text Key220569357
Report Number1219913-2019-00237
Device Sequence Number1
Product Code LFX
UDI-Device Identifier00630414201412
UDI-Public00630414201412
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K003412
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/18/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number10310283
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/24/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/05/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age26 YR
-
-